FDA Requests Sarepta Therapeutics Suspend Distribution of Elevidys and Places Clinical Trials on Hold for Multiple Gene Therapy Products Following 3 Deaths By FDA – Press releases
FDA Issues Warning Letters to Firms Marketing Products Containing 7-Hydroxymitragynine By FDA – Press releases
FDA Approves Gardenia (Genipin) Blue Color Additive While Encouraging Faster Phase-Out of FD&C Red No. 3 By FDA – Press releases
